Clare Hoskins Selected Research

Clare Hoskins Research Topics

12	Neoplasms (Cancer) 05/2024 - 01/2017
6	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 12/2010
5	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2020
3	Infections 04/2022 - 01/2018
3	Adenocarcinoma 01/2018 - 12/2010
2	COVID-19 10/2021 - 09/2020
2	Inflammation (Inflammations) 10/2021 - 03/2018
2	Hyperthermia 01/2019 - 06/2012
2	Liver Neoplasms (Liver Cancer) 05/2018 - 04/2018
2	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 04/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2024
1	Wounds and Injuries (Trauma) 02/2023
1	Coinfection 04/2022
1	Disease Progression 10/2021
1	Carcinoma (Carcinomatosis) 08/2020
1	Intestinal Diseases (Diseases, Intestinal) 03/2018
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017

5	PolymersIBA 02/2023 - 12/2010
3	HydrogelsIBA 05/2024 - 08/2020
3	Gemcitabine FDA Link 09/2023 - 11/2017
2	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 04/2024
2	Liposomes (Liposome)IBA 01/2023 - 12/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 01/2018
2	VaccinesIBA 10/2021 - 09/2020
2	Drug CarriersIBA 08/2020 - 09/2018
2	Cytochromes c (Cytochrome c)IBA 05/2018 - 04/2018
1	GoldIBA 09/2023
1	CarbonIBA 09/2023
1	RutheniumIBA 08/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2021
1	Letrozole (Femara)FDA LinkGeneric 12/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	CytokinesIBA 10/2021
1	AllylamineIBA 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2020
1	ferric oxide (iron oxide)IBA 01/2019
1	Stimuli Responsive PolymersIBA 08/2018
1	Apoptosis Regulatory ProteinsIBA 05/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2018
1	Antineoplastic Agents (Antineoplastics)IBA 04/2018
1	benzocycloheptapyridineIBA 01/2018
1	ProdrugsIBA 11/2017
1	PolyaminesIBA 08/2017
1	Oxidoreductases (Dehydrogenase)IBA 01/2017
1	CholesterolIBA 01/2017
1	Coenzyme A (CoA)IBA 01/2017
1	pitavastatin (itavastatin)FDA Link 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	geranylgeraniolIBA 01/2017
1	Contrast MediaIBA 06/2012
1	lissamine rhodamine B (sulforhodamine B)IBA 12/2010
1	Coloring Agents (Dyes)IBA 12/2010